Literature DB >> 10449979

A surgical and pathological based classification of resective treatment of pancreatic cancer. Summary of an international workshop on surgical procedures in pancreatic cancer.

S Pedrazzoli1, H G Beger, H Obertop, A Andrén-Sandberg, L Fernández-Cruz, D Henne-Bruns, J Lüttges, J P Neoptolemos.   

Abstract

BACKGROUND: The extent of pancreatic resection and lymphadenectomy, both for Kausch-Whipple pancreatoduodenectomy and for left pancreatectomy, is variable between surgeons, according to their training.
METHODS: On May 30, 1998, a consensus conference on the surgical treatment of pancreatic cancer took place in Castelfranco Veneto, Italy. A group of 29 European surgeons and pathologists, recognized as international experts, analyzed the surgical and pathological procedures used in European countries to resect pancreatic cancer and examine the specimen.
RESULTS: A general agreement was reached on the definitions of standard , 'radical and 'extended radical Kausch-Whipple pancreatoduodenectomy for carcinoma of the head of the pancreas, and standard and 'radical left pancreatectomy for carcinoma of the body and tail of the pancreas. Segmental venous resection, as well as adjacent organ resection, can be performed at the time of standard, radical or extended radical pancreatoduodenectomy or left pancreatectomy if required. The pylorus-preserving procedure is contraindicated only for carcinomas of the anteriorsuperior part of the head of the pancreas. Guidelines for a standardized pathological examination of the resected specimen were produced.
CONCLUSION: Adoption of the recommended terminology will improve outcome comparisons between institutions performing the different procedures. Moreover, standardization of operations, terminology and pathological reporting is essential for prospective randomized trials comparing different operations either alone or within the context of adjuvant therapy studies.

Entities:  

Mesh:

Year:  1999        PMID: 10449979     DOI: 10.1159/000018744

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  36 in total

Review 1.  Extent of lymphadenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas.

Authors:  S Pedrazzoli; F Michelassi
Journal:  J Gastrointest Surg       Date:  2000 May-Jun       Impact factor: 3.452

2.  Peri-operative outcomes for pancreatoduodenectomy in India: a multi-centric study.

Authors:  Parul J Shukla; Savio G Barreto; Mms Bedi; N Bheerappa; Adarsh Chaudhary; Md Gandhi; M Jacob; S Jesvanth; Dg Kannan; Vinay K Kapoor; A Kumar; Kk Maudar; Hariharan Ramesh; Ra Sastry; Rajan Saxena; Ajit Sewkani; S Sharma; Shailesh V Shrikhande; A Singh; Rajneesh K Singh; R Surendran; Subodh Varshney; V Verma; V Vimalraj
Journal:  HPB (Oxford)       Date:  2009-12       Impact factor: 3.647

3.  Extended pancreatic resections and lymphadenectomy: An appraisal of the current evidence.

Authors:  Shailesh V Shrikhande; Savio G Barreto
Journal:  World J Gastrointest Surg       Date:  2010-02-27

4.  Mode of spread in the early phase of lymphatic metastasis in pancreatic ductal adenocarcinoma: prognostic significance of nodal microinvolvement.

Authors:  Dean Bogoevski; Emre F Yekebas; Paulus Schurr; Jussuf T Kaifi; Asad Kutup; Andreas Erbersdobler; Klaus Pantel; Jakob R Izbicki
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

5.  How surgeons make decisions: authority and evidence.

Authors:  Huug Obertop
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

6.  Can intestinal innervation be preserved in pancreatoduodenectomy for cancer? Results of an anatomical study.

Authors:  M Nano; H Dal Corso; M Ferronato; M Solej; J P Hornung
Journal:  Surg Radiol Anat       Date:  2003-02-25       Impact factor: 1.246

7.  Extended resection for pancreatic adenocarcinoma.

Authors:  T M van Gulik; A Nakao; H Obertop
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

8.  Striving for a better operative outcome: 101 pancreaticoduodenectomies.

Authors:  A W C Kow; S P Chan; A Earnest; C Y Chan; K Lim; S Y Chong; K H Lim; C K Ho; S P Chew; K H Liau
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

9.  Strong prognostic value of nodal and bone marrow micro-involvement in patients with pancreatic ductal carcinoma receiving no adjuvant chemotherapy.

Authors:  Emre-F Yekebas; Dean Bogoevski; Michael Bubenheim; Björn-Christian Link; Jussuf-T Kaifi; Robin Wachowiak; Oliver Mann; Asad Kutup; Guellue Cataldegirmen; Lars Wolfram; Andreas Erbersdobler; Christoph Klein; Klaus Pantel; Jakob-R Izbicki
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

10.  Tumor relapse after pancreatic cancer resection is detected earlier by 18-FDG PET than by CT.

Authors:  Cosimo Sperti; Claudio Pasquali; Sergio Bissoli; Franca Chierichetti; Guido Liessi; Sergio Pedrazzoli
Journal:  J Gastrointest Surg       Date:  2009-09-24       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.